Cargando…

The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China

PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junlong, Shen, Kui, Hu, Jun, Li, Xinyue, Liu, Jie, Du, Yonghong, Huang, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847415/
https://www.ncbi.nlm.nih.gov/pubmed/33531848
http://dx.doi.org/10.2147/RMHP.S290565
_version_ 1783644929683095552
author Li, Junlong
Shen, Kui
Hu, Jun
Li, Xinyue
Liu, Jie
Du, Yonghong
Huang, Kang
author_facet Li, Junlong
Shen, Kui
Hu, Jun
Li, Xinyue
Liu, Jie
Du, Yonghong
Huang, Kang
author_sort Li, Junlong
collection PubMed
description PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in two phases using random sampling on the spot and an online survey. In the first phase, data from 239 clinicians were investigated in exploratory factor analysis. In the second phase, 513 valid questionnaires were collected and used for confirmatory factor analysis. RESULTS: The scale developed in this study has three dimensions (organization support, process identity, and effect perception) and a total of 21 items. Cronbach’s alpha of each dimension was higher than 0.9. The 3-factor model had enough fitness (χ2/df = 5.602, NFI = 0.926, IFI = 0.938, CFI = 0.938, RFI = 0.914, TLI = 0.929, RMSEA = 0.095, RMR = 0.045). The standardized factor loadings of 21 variables were between 0.742 and 0.949. The average variance extracted (AVE) of each dimension was higher than 0.7, and the construct reliability (CR) of the dimensions was higher than 0.9. The Chi-square difference test results showed that the difference value between the unlimited and limited model of each two potential constructs was higher than 3.84 (P < 0.001). CONCLUSION: The clinicians’ satisfaction scale developed in this study has good construct validity, convergent validity, discriminant validity, internal consistency, and item discrimination. This suggests its usefulness as a tool to assess the satisfaction of clinicians in the implementation of CP in China.
format Online
Article
Text
id pubmed-7847415
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78474152021-02-01 The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China Li, Junlong Shen, Kui Hu, Jun Li, Xinyue Liu, Jie Du, Yonghong Huang, Kang Risk Manag Healthc Policy Original Research PURPOSE: To develop a satisfaction scale of Chinese clinicians with Clinical Pathway (CP) implementation and evaluate its validity, reliability and item discrimination. MATERIALS AND METHODS: Literature review, in-person interviews, and Delphi were used to design the scale. Data were collected in two phases using random sampling on the spot and an online survey. In the first phase, data from 239 clinicians were investigated in exploratory factor analysis. In the second phase, 513 valid questionnaires were collected and used for confirmatory factor analysis. RESULTS: The scale developed in this study has three dimensions (organization support, process identity, and effect perception) and a total of 21 items. Cronbach’s alpha of each dimension was higher than 0.9. The 3-factor model had enough fitness (χ2/df = 5.602, NFI = 0.926, IFI = 0.938, CFI = 0.938, RFI = 0.914, TLI = 0.929, RMSEA = 0.095, RMR = 0.045). The standardized factor loadings of 21 variables were between 0.742 and 0.949. The average variance extracted (AVE) of each dimension was higher than 0.7, and the construct reliability (CR) of the dimensions was higher than 0.9. The Chi-square difference test results showed that the difference value between the unlimited and limited model of each two potential constructs was higher than 3.84 (P < 0.001). CONCLUSION: The clinicians’ satisfaction scale developed in this study has good construct validity, convergent validity, discriminant validity, internal consistency, and item discrimination. This suggests its usefulness as a tool to assess the satisfaction of clinicians in the implementation of CP in China. Dove 2021-01-26 /pmc/articles/PMC7847415/ /pubmed/33531848 http://dx.doi.org/10.2147/RMHP.S290565 Text en © 2021 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Junlong
Shen, Kui
Hu, Jun
Li, Xinyue
Liu, Jie
Du, Yonghong
Huang, Kang
The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title_full The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title_fullStr The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title_full_unstemmed The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title_short The Clinicians’ Satisfaction with Clinical Pathway Implementation: Preliminary Development of an Assessment Scale in China
title_sort clinicians’ satisfaction with clinical pathway implementation: preliminary development of an assessment scale in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847415/
https://www.ncbi.nlm.nih.gov/pubmed/33531848
http://dx.doi.org/10.2147/RMHP.S290565
work_keys_str_mv AT lijunlong theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT shenkui theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT hujun theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT lixinyue theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT liujie theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT duyonghong theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT huangkang theclinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT lijunlong clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT shenkui clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT hujun clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT lixinyue clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT liujie clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT duyonghong clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina
AT huangkang clinicianssatisfactionwithclinicalpathwayimplementationpreliminarydevelopmentofanassessmentscaleinchina